IANS LIVE-1 IN 3 SUFFER FROM FATTY LIVER IN INDIA, PREDATES DIABETES: DR JITENDRA SINGH
May 12, 2025
Fixtures

No live matches found !

No matches found !

Result7 May 2025
Match 57
KKR
KKR
179/6 (20 ov)
CSK
CSK
183/8 (19.4 ov)
CSK won by 2 wickets
Result6 May 2025
Match 56
MI
MI
155/8 (20 ov)
GT
GT
147/7 (19 ov)
GT won by 3 wickets (DLS method)
Result5 May 2025
Match 55
SRH
SRH
0/0 ( ov)
DC
DC
133/7 (20 ov)
No Result
Result4 May 2025
Match 54
PBKS
PBKS
236/5 (20 ov)
LSG
LSG
199/7 (20 ov)
PBKS won by 37 runs
Result4 May 2025
Match 53
KKR
KKR
206/4 (20 ov)
RR
RR
205/8 (20 ov)
KKR won by 1 run
Result3 May 2025
Match 52
RCB
RCB
213/5 (20 ov)
CSK
CSK
211/5 (20 ov)
RCB won by 2 runs
Result2 May 2025
Match 51
GT
GT
224/6 (20 ov)
SRH
SRH
186/6 (20 ov)
GT won by 38 runs
Result1 May 2025
Match 50
RR
RR
117/10 (16.1 ov)
MI
MI
217/2 (20 ov)
MI won by 100 runs
Result30 April 2025
Match49
CSK
CSK
190/10 (19.2 ov)
PBKS
PBKS
194/6 (19.4 ov)
PBKS won by 4 wickets
Result29 April 2025
Match 48
DC
DC
190/9 (20 ov)
KKR
KKR
204/9 (20 ov)
KKR won by 14 runs
Result28 April 2025
Match 47
RR
RR
212/2 (15.5 ov)
GT
GT
209/4 (20 ov)
RR won by 8 wickets
Result27 April 2025
Match 46
DC
DC
162/8 (20 ov)
RCB
RCB
165/4 (18.3 ov)
RCB won by 6 wickets
Result27 April 2025
Match 45
MI
MI
215/7 (20 ov)
LSG
LSG
161/10 (20 ov)
MI won by 54 runs
Result26 April 2025
Match 44
KKR
KKR
7/0 (1 ov)
PBKS
PBKS
201/4 (20 ov)
No result
Result25 April 2025
Match 43
CSK
CSK
154/10 (19.5 ov)
SRH
SRH
155/5 (18.4 ov)
SRH won by 5 wickets
Result24 April 2025
Match 42
RCB
RCB
205/5 (20 ov)
RR
RR
194/9 (20 ov)
RCB won by 11 runs
Result23 April 2025
Match 41
SRH
SRH
143/8 (20 ov)
MI
MI
146/3 (15.4 ov)
MI won by 7 wickets
Result22 April 2025
Match 40
LSG
LSG
159/6 (20 ov)
DC
DC
161/2 (17.5 ov)
DC won by 8 wickets
Result21 April 2025
Match 39
KKR
KKR
159/8 (20 ov)
GT
GT
198/3 (20 ov)
GT won by 39 runs
Result20 April 2025
Match 38
MI
MI
177/1 (15.4 ov)
CSK
CSK
176/5 (20 ov)
MI won by 9 wickets

1 in 3 suffer from fatty liver in India, predates diabetes: Dr Jitendra Singh

1 in 3 Indian suffers from fatty liver, predates diabetes: Dr Jitendra Singh

New Delhi, July 5 (IANS) Every third person in India has a fatty liver, which predates Type-2 diabetes and other metabolic disorders, said Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, on Friday.

“Non-alcoholic fatty liver disease (NAFLD) -- a common metabolic liver disorder -- can progress to cirrhosis and primary liver cancer eventually. It predates diabetes, hypertension, heart disease, and many other diseases. As an endocrinologist myself, I understand the nuances of fatty liver and its relation with diabetes and other metabolic disorders,” said Dr Jitendra, a nationally renowned Diabetologist.

He was speaking at the launch of the Indo-French Liver and Metabolic Disease Network (InFLiMeN) -- a virtual node to prevent and cure metabolic liver diseases at the Institute of Liver and Biliary Sciences in the national Capital.

Eleven French and 17 Indian doctors will jointly work in this node.

“Both the Indian subcontinent and Europe are attributable to changes in lifestyle, diet and importantly metabolic syndromes such as diabetes and obesity which have contributed to a significant rise in NAFLD,” the minister said.

He added that in the Indian subcontinent, NAFLD occurs in about 20 per cent of non-obese patients, whereas in the West, most NAFLD is associated with obesity.

He further noted that both India and France have “a considerable burden of alcoholic liver disease (ALD).”

The Union Minister explained that both NAFLD and ALD exhibit a very similar progression from steatosis to steatohepatitis, cirrhosis, and HCC.

“India became a global leader not just in curative healthcare but also in preventive healthcare,” said Dr. Jitendra, highlighting India's progress in the last decade.

He stressed the need for India-specific diagnostics “as our phenotype is different”.

“There is an urgent need to develop simple, low-cost diagnostic tests for the detection of different stages of fatty liver and their progression to severe, full-blown diseases,” he said.

Importantly, he noted that the “approaches and algorithms should suit the Indian context, be low-priced, and have a point of care”.